Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.950
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Climb Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 146.18 | 93.11 | 43.59 | 46.92 | 20.49 | 21.22 |
Short-Term Investments | 47.18 | 13.69 | 79.98 | 89.56 | - | - |
Cash & Short-Term Investments | 193.35 | 106.8 | 123.57 | 136.48 | 20.49 | 21.22 |
Cash Growth | 79.97% | -13.57% | -9.46% | 566.18% | -3.47% | - |
Other Receivables | 0.99 | 2.42 | 6.59 | 7.02 | - | - |
Receivables | 0.99 | 2.42 | 6.59 | 7.02 | - | - |
Prepaid Expenses | 0.74 | 0.88 | 3.88 | 4.4 | 1.5 | 0.03 |
Other Current Assets | 2.53 | 0.15 | 0.36 | 0.35 | 0.01 | 0.04 |
Total Current Assets | 197.61 | 110.26 | 134.39 | 148.25 | 22 | 21.28 |
Property, Plant & Equipment | 0.01 | 0.2 | 0.47 | - | - | - |
Long-Term Investments | 24.58 | - | - | 24.92 | - | - |
Other Long-Term Assets | - | 0.02 | 0.13 | 0.07 | 2.63 | 0.11 |
Total Assets | 222.2 | 110.47 | 134.99 | 173.24 | 24.63 | 21.4 |
Accounts Payable | 0.29 | 0.07 | 0.75 | 1.4 | 1.29 | 0.71 |
Accrued Expenses | 2.33 | 1.23 | 5.05 | 4.63 | 1.22 | 0.07 |
Current Portion of Leases | 0.06 | 0.33 | 0.3 | - | - | - |
Other Current Liabilities | 0.74 | 1.2 | - | - | - | - |
Total Current Liabilities | 3.42 | 2.83 | 6.1 | 6.03 | 2.51 | 0.78 |
Long-Term Leases | - | 0.02 | 0.18 | - | - | - |
Other Long-Term Liabilities | - | 0.02 | - | 0.01 | - | - |
Total Liabilities | 3.42 | 2.87 | 6.28 | 6.04 | 2.51 | 0.78 |
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 440.03 | 263.58 | 249.93 | 242.94 | 3.15 | 1.91 |
Retained Earnings | -221.46 | -155.98 | -120.86 | -75.62 | -28.14 | -7.47 |
Comprehensive Income & Other | 0.2 | -0 | -0.36 | -0.12 | - | - |
Total Common Equity | 218.78 | 107.6 | 128.72 | 167.2 | -24.98 | -5.56 |
Shareholders' Equity | 218.78 | 107.6 | 128.72 | 167.2 | 22.12 | 20.61 |
Total Liabilities & Equity | 222.2 | 110.47 | 134.99 | 173.24 | 24.63 | 21.4 |
Total Debt | 0.06 | 0.35 | 0.48 | - | - | - |
Net Cash (Debt) | 217.87 | 106.45 | 123.09 | 161.4 | 20.49 | 21.22 |
Net Cash Growth | 103.67% | -13.52% | -23.74% | 687.81% | -3.47% | - |
Net Cash Per Share | 5.70 | 3.94 | 4.68 | 13.16 | 9.36 | 12.78 |
Filing Date Shares Outstanding | 67.22 | 27.72 | 26.57 | 26.57 | 3.48 | 1.66 |
Total Common Shares Outstanding | 67.22 | 27.7 | 26.57 | 26.24 | 3.42 | 1.66 |
Working Capital | 194.19 | 107.42 | 128.3 | 142.22 | 19.49 | 20.5 |
Book Value Per Share | 3.25 | 3.88 | 4.84 | 6.37 | -7.31 | -3.35 |
Tangible Book Value | 218.78 | 107.6 | 128.72 | 167.2 | -24.98 | -5.56 |
Tangible Book Value Per Share | 3.25 | 3.88 | 4.84 | 6.37 | -7.31 | -3.35 |
Source: S&P Capital IQ. Standard template. Financial Sources.